PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 2 mg vial with 1 mL of sterile water for injection, what concentration do I end up with?

Asked 18 Mar 2025Modified 13 months agoViewed 39k times
30

What I have: 2 mg · 1 mL · sterile water for injection.

This should be a straightforward calculation and I keep getting two different answers.

The numbers are arbitrary; the method is what I am after.

Can someone show the working rather than just the answer?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
JH
askedjana_horakova15k2718 Mar 2025
5Related: the same reasoning applies to the counter-ion question. – p_mkhize 5 months ago
add a comment

5 Answers

Accepted answer first, then by votes
99

Accepted answer

Put another way, this is not exotic. It is just the difference between doing it deliberately and doing it approximately.

The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
DV
answered · accepteddead_volume49k3821 Mar 2025
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
39

The relevant detail is that read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
SS
answeredswirl_dont_shake19k288 Jul 2025
31

Put another way, if the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.

Check the barrel marking, not your memory of it.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

edited 13 Apr 2025 by Dr_Nadia_Farsi — added the placebo-arm figures

shareimprove this answerflag
DF
answeredDr_Nadia_Farsi90k25812 Apr 2025
The distinction between purity and content cannot be repeated often enough here. – ruaidhri_o_shea 8 months ago
add a comment
25

The relevant detail is that gentle swirling dissolves a lyophilised cake far better than vigorous shaking, which causes aeration and aggregation.

Number of stopper piercings matters less than the gauge doing the piercing.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

The caveat on all of this is that it assumes the vial contains what the label says.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
LS
answeredlow_dead_space42k381 Apr 2025
4I have seen exactly this failure mode twice and both times it was the diluent. – kwn_analytical 5 months ago
5The distinction between purity and content cannot be repeated often enough here. – ruaidhri_o_shea 6 months ago
add a comment
22

Worth being precise here: the distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.

If the material arrived warm and it was lyophilised, test it and proceed on the result.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
MS
answeredmarta_szymanska17k385 Jun 2025
7Minor: the trial name is hyphenated in the original publication. – Dr_Fatima_Belkacem 9 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.